A Phase II, Open-label, Single Arm, Multicenter Study of Avelumab With Hypofractionated Radiation in Adult Subjects With Transformed IDH Mutant Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Avelumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Feb 2019.
- 13 Feb 2017 Status changed from not yet recruiting to recruiting.
- 24 Nov 2016 New trial record